triflupromazine has been researched along with Basal Ganglia Diseases in 5 studies
Triflupromazine: A phenothiazine used as an antipsychotic agent and as an antiemetic.
triflupromazine : A member of the class of phenothiazines that is 10H-phenothiazine having a trifluoromethyl subsitituent at the 2-position and a 3-(dimethylamino)propyl group at the N-10 position.
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DARLING, HF | 1 |
| SHEV, EE | 1 |
| Walter, H | 1 |
| Snyder, SH | 1 |
| Greenberg, D | 1 |
| Yamumura, HI | 1 |
| Doshi, HV | 1 |
| Shah, SS | 1 |
| Mehta, RM | 1 |
5 other studies available for triflupromazine and Basal Ganglia Diseases
| Article | Year |
|---|---|
Extrapyramidal symptoms of triflupromazine, mepazine, prochlorperazine.
Topics: Basal Ganglia Diseases; Extrapyramidal Tracts; Humans; Phenothiazines; Prochlorperazine; Tranquilizi | 1959 |
Spinal fluid electrophoresis pattern of a patient treated with triflupromazine.
Topics: Basal Ganglia Diseases; Cerebrospinal Fluid; Disease; Electrophoresis; Extrapyramidal Tracts; Tranqu | 1960 |
[Four cases of extrapyramidal effects following the treatment of hyperemesis gravidarum with triflupromazin (author's transl)].
Topics: Adolescent; Adult; Basal Ganglia Diseases; Female; Humans; Hyperemesis Gravidarum; Pregnancy; Triflu | 1976 |
Antischizophrenic drugs: affinity for muscarinic cholinergic receptor sites in the brain predicts extrapyramidal effects.
Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Binding, Competitive; Brain; Chlorpromazine; | 1974 |
Acute reversible neurological manifestations due to triflupromazine therapy. A report of three cases.
Topics: Adult; Basal Ganglia Diseases; Female; Humans; Male; Movement Disorders; Seizures; Triflupromazine | 1972 |